BPG is committed to discovery and dissemination of knowledge
Retrospective Study
Copyright: ©Author(s) 2026.
World J Stem Cells. May 26, 2026; 18(5): 119123
Published online May 26, 2026. doi: 10.4252/wjsc.v18.i5.119123
Table 1 Baseline characteristics of patients stratified by different levels of cancer stem cell expression, n (%)
Indices
CSC low expression (n = 76)
CSC high expression (n = 56)
Statistic
P value
Age (years)55.05 ± 9.4653.96 ± 9.76t = 0.6380.525
Gender
    Male59 (77.63)40 (71.43)χ2 = 0.6720.412
    Female17 (22.37)16 (28.57)
HBV infection
    Yes49 (64.47)43 (76.79)χ2 = 2.3690.124
    No27 (35.53)13 (23.21)
Liver cirrhosis
    Yes43 (56.58)32 (57.14)χ2 = 0.0040.948
    No33 (43.42)24 (42.86)
AFP (ng/mL)97.71 (55.82-204.30)106.71 (51.90-185.17)Z = 2.2300.640
AFP
    < 400 ng/mL66 (86.84)54 (96.43)χ2 = 3.2160.073
    ≥ 400 ng/mL10 (13.16)2 (3.57)
Tumor maximum diameter (cm)4.98 ± 2.435.62 ± 2.31t = -1.5370.127
Tumor maximum diameter
    ≤ 5 cm42 (55.26)21 (37.50)χ2 = 4.3380.037
    > 5 cm34 (44.74)35 (62.50)
Multifocal
    Yes16 (21.05)17 (30.36)χ2 = 1.4520.228
    No60 (78.95)39 (69.64)
Microvascular invasion
    Yes26 (34.21)26 (46.43)χ2 = 2.0660.151
    No50 (65.79)30 (53.57)
Edmondson classification
    Class I-II49 (64.47)25 (44.64)χ2 = 5.1990.023
    Class III-IV27 (35.53)31 (55.36)


Write to the Help Desk